Aigen Investment Management, LP Bio Rad Laboratories, Inc. Transaction History

Aigen Investment Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$268.26 - $339.48 $469,991 - $594,768	1,752 Added 259.56%	2,427 $662,000
Q1 2024 May 14, 2024	SELL	$304.11 - $351.99 $138,065 - $159,803	-454 Reduced 40.21%	675 $233,000
Q4 2023 Feb 09, 2024	BUY	$269.37 - $365.04 $304,118 - $412,130	1,129 New	1,129 $364,000
Q4 2022 Feb 10, 2023	BUY	$351.71 - $456.01 $705,530 - $914,756	2,006 Added 281.35%	2,719 $1.14 Million
Q3 2022 Nov 09, 2022	BUY	$412.59 - $563.26 $97,783 - $133,492	237 Added 49.79%	713 $297,000
Q2 2022 Aug 02, 2022	BUY	$463.67 - $597.16 $220,706 - $284,248	476 New	476 $236,000

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.19B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.